Characterization of the Role of Chromosome 1p Deletion in MYCN-Amplified Neuroblastoma |
University of California San Francisco / Miller Huang, PhD |
Young Investigator Grants |
2013 |
California |
Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma |
University of California San Francisco / Ozlem Aksoy, PhD |
Young Investigator Grants |
2015 |
California |
Modeling Anaplastic Medulloblastoma using Cerebellar Stem Cells |
Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, PhD |
Innovation Grants |
2011 |
California |
Development of a comprehensive liquid biopsy-based genomics platform for pediatric solid tumors |
Children’s Hospital Los Angeles / Jaclyn Biegel |
Catalyst Grants |
2023 |
California |
MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis |
Stanford University / Feng Pan, PhD |
Young Investigator Grants |
2019 |
California |
Predicting Outcome and Ameliorating Toxicities of the Immunotherapy of Neuroblastoma |
University of California, San Diego / Alice Yu, MD, PhD |
Innovation Grants |
2011 |
California |
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine / Alice Bertaina, MD/PhD |
Reach Grants |
2019 |
California |
The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia
|
Children’s Hospital Los Angeles / Markus Muschen |
Innovation Grants |
2008 |
California |
Factors Affecting Parental Satisfaction, Anxiety and Comprehension of the Informed Consent in Pediatric Oncology Clinical Trials |
University of California, San Diego / Paula Aristizabal, MD |
Psychosocial Grants |
2015 |
California |
Developing and Distributing a Pediatric Spinal Cord High-grade Glioma Model |
Stanford University / Michelle Monje, MD/PhD |
Innovation Grants |
2016 |
California |